Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes
Date first appeared online | 27/01/2022 |
DOI | 10.1093/immadv/ltac002 |
Authors | Luzio S., Dunseath G., Holland G., Cheung I. |
Journal Name | Immunotherapy Advances |
Volume | 2 |
Documents
- 61405_VoR.pdf , Book, © The Author(s) 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License